# IMMUNO-XAI Biological Interpretation

## Computational Analysis

- **Pipeline:** IMMUNO-XAI
- **Input cells:** 913
- **LLM:** groq/compound-mini

---

**# 1. Overall Finding**  
- The computational pipeline classified 913 single‑cell profiles.  
- **Insufficient‑Evidence** dominates (865 cells, ≈ 95 % of the dataset) with a mean confidence of 0.0.  
- Minor fractions were assigned to **Immune‑Excluded** (32 cells, ≈ 3.5 %, confidence 1.0) and **Immune‑Suppressed** (15 cells, ≈ 1.6 %, mean confidence ≈ 0.78).  
- A single cell was labeled **Myeloid‑Dominant** (confidence ≈ 0.26).  
- Immune‑score, pathway‑score, and ML‑prediction summaries show very low average values and high variability, indicating weak overall signal.

---

**# 2. Immune‑State Interpretation**  

| Immune state | Cell count | Fraction | Mean confidence |
|--------------|------------|----------|-----------------|
| Insufficient‑Evidence | 865 | 0.947 | 0.0 |
| Immune‑Excluded | 32 | 0.035 | 1.0 |
| Immune‑Suppressed | 15 | 0.016 | 0.78 |
| Myeloid‑Dominant | 1 | 0.001 | 0.26 |

- **Detected immune states:** The pipeline detects three biologically interpretable states (Excluded, Suppressed, Myeloid‑Dominant) but they together represent < 2 % of the cells.  
- **Relative abundance:** The vast majority of cells lack sufficient evidence to assign a definitive immune phenotype.  
- **Confidence:** High confidence is only present for the Immune‑Excluded cells (confidence = 1.0). Immune‑Suppressed cells have moderate confidence (≈ 0.78).  
- **Insufficient‑Evidence significance:** This category indicates that the model could not reliably infer an immune state from the available transcriptional signal. Consequently, any downstream biological conclusions must be limited to the small subset of cells with confident assignments.  
- **Evidence strength:** The dataset provides **limited evidence** for distinct immune states; the overwhelming Insufficient‑Evidence label precludes robust population‑level statements.

---

**# 3. Cluster‑Level Interpretation**  

| Cluster | n cells | Dominant state | Fraction dominant | Other states present |
|---------|---------|----------------|--------------------|----------------------|
| 0 | 41 | Insufficient‑Evidence | 1.00 | – |
| 1 | 137 | Insufficient‑Evidence | 0.88 | Immune‑Excluded (10), Immune‑Suppressed (6) |
| 2 | 84 | Insufficient‑Evidence | 0.92 | Immune‑Excluded (4), Immune‑Suppressed (2), Myeloid‑Dominant (1) |
| 3 | 157 | Insufficient‑Evidence | 0.94 | Immune‑Excluded (7), Immune‑Suppressed (2) |
| 4 | 110 | Insufficient‑Evidence | 0.96 | Immune‑Excluded (3), Immune‑Suppressed (1) |
| 5 | 60 | Insufficient‑Evidence | 1.00 | – |
| 6 | 45 | Insufficient‑Evidence | 1.00 | – |
| 7 | 117 | Insufficient‑Evidence | 0.91 | Immune‑Excluded (8), Immune‑Suppressed (3) |
| 8 | 40 | Insufficient‑Evidence | 1.00 | – |
| 9 | 122 | Insufficient‑Evidence | 0.99 | Immune‑Suppressed (1) |

- Every cluster is dominated by **Insufficient‑Evidence** cells.  
- Clusters 1, 2, 3, 4, 7 contain the few Immune‑Excluded or Immune‑Suppressed cells, but these represent a minor proportion of each cluster.  
- No cluster shows a clear, exclusive enrichment for a biologically interpretable state; therefore, **forced biological interpretation of these clusters is not justified**.

---

**# 4. Immune‑Signal Interpretation**  

| Score | Mean | Median | Std | Max |
|-------|------|--------|-----|-----|
| t‑cell activity | 0.0007 | 0.0 | 0.0218 | 0.658 |
| cytotoxic activity | 0.0 | 0.0 | 0.0 | 0.0 |
| myeloid signal | 0.0067 | 0.0 | 0.0288 | 0.295 |
| immune suppression | 0.0053 | 0.0 | 0.0338 | 0.478 |
| inflammatory signal | 0.0114 | 0.0 | 0.0749 | 1.393 |
| antigen presentation | 0.0407 | 0.0 | 0.0665 | 0.413 |

- All immune scores are **near zero on average**, with medians at 0, indicating that most cells lack detectable activity for the measured immune functions.  
- The **maximum values** show that a few individual cells attain higher scores (e.g., inflammatory signal up to 1.39), but these are rare and not reflected in the bulk statistics.  
- Consequently, the data provide **limited evidence** for robust immune activation, cytotoxicity, or antigen presentation at the population level.

---

**# 5. Pathway Interpretation**  

| Pathway | Mean | Median | Std |
|---------|------|--------|-----|
| glycolysis | 0.0 | –0.0065 | 0.434 |
| oxidative phosphorylation | ~0 | 0.0723 | 0.420 |
| fatty‑acid metabolism | ~0 | 0.0114 | 0.355 |
| interferon response | ~0 | –0.0732 | 0.331 |
| inflammatory signaling | ~0 | –0.2428 | 0.492 |
| chemokine activity | ~0 | –0.0935 | 0.623 |

- Mean pathway scores hover around zero, and the medians are also close to zero, indicating **no consistent up‑ or down‑regulation** across the dataset.  
- Standard deviations are relatively large compared with the means, reflecting **high cell‑to‑cell variability** but not a coherent directional shift.  
- Thus, the analysis does **not support strong activation or suppression** of the listed metabolic or inflammatory pathways.

---

**# 6. Machine‑Learning Interpretation**  

- **Prediction count:** 912 cells (one cell likely omitted from the ML step).  
- **Class distribution:** 869 Insufficient‑Evidence, 31 Immune‑Excluded, 12 Immune‑Suppressed.  
- The model is **highly imbalanced** toward the Insufficient‑Evidence class (≈ 95 %).  
- No accuracy or balanced‑accuracy metrics are provided, but with such imbalance, overall accuracy could be misleading (e.g., a naïve classifier predicting “Insufficient‑Evidence” for every cell would achieve ≈ 95 % accuracy).  
- **Minority‑class performance** (Immune‑Excluded, Immune‑Suppressed) cannot be assessed reliably without per‑class metrics; the small number of examples (31 and 12) limits statistical confidence.  
- **Interpretation caution:** Predictions for the minority classes should be treated as tentative, and any biological conclusions drawn from them must acknowledge the limited training signal.

---

**# 7. XAI Interpretation**  

- SHAP analysis (mean absolute SHAP) highlights the following top contributors (ordered by importance):  

  1. **immune_myeloid_signal** (0.125)  
  2. **immune_immune_suppression** (0.118)  
  3. **immune_antigen_presentation** (0.024)  
  4. Principal components (PC1, PC36, PC39, …)  

- These features **contribute most to the model’s output** (i.e., to the classification decision) but **do not imply that the biological processes themselves cause the assigned immune state**.  
- The prominence of myeloid and immune‑suppression signals aligns with the few cells labeled Immune‑Suppressed, yet the SHAP values reflect model reliance on these features rather than definitive biological causality.  
- The remaining importance is distributed across many PCs, suggesting the model also leverages broader transcriptional variation that is not directly interpretable without further annotation.

---

**# 8. Integrated Biological Interpretation**  

- The dataset contains **very few cells with confident immune‑state assignments** (Immune‑Excluded, Immune‑Suppressed).  
- Correspondingly, **immune‑related scores** (t‑cell, myeloid, suppression, inflammatory) are near zero on average, and **pathway scores** show no consistent activation.  
- The **ML model** mirrors the underlying class imbalance, predicting the dominant Insufficient‑Evidence label for most cells; minority‑class predictions are based on limited evidence.  
- **XAI results** indicate that when the model does predict a non‑Insufficient‑Evidence state, it leans on myeloid and immune‑suppression signals, but given the paucity of such cells, this pattern cannot be generalized to the whole population.  
- Overall, the computational evidence **does not support a robust conclusion** about the presence of distinct immune microenvironments or pathway alterations in this sample.

---

**# 9. Limitations**  

1. **High proportion of Insufficient‑Evidence** (≈ 95 %) limits the ability to draw biologically meaningful conclusions.  
2. **Low confidence** for the majority of cells; many predictions have a mean confidence of 0.0.  
3. **Class imbalance** in the ML step hampers reliable assessment of minority‑class performance.  
4. **Absence of accuracy or validation metrics** prevents evaluation of model reliability.  
5. **Immune and pathway scores** have low means and medians, with large variability, indicating weak signal.  
6. **SHAP importance** reflects model contribution, not causation; interpretation must remain cautious.  
7. **Single‑cell resolution** is limited to 913 cells, which may be insufficient to capture rare immune states.  
8. **No external validation** (e.g., orthogonal assays) is provided to corroborate the computational assignments.

---

**# 10. Final Conclusion**  
The analysis reveals that the overwhelming majority of cells lack sufficient transcriptional evidence to assign a specific immune state, and the few cells with confident Immune‑Excluded or Immune‑Suppressed labels are too scarce to support strong biological claims about immune activity or pathway modulation in this sample.

---

## One-Line Conclusion  
The dataset provides limited, low‑confidence evidence for distinct immune states, with most cells classified as Insufficient‑Evidence, precluding robust biological interpretation.

---

## Interpretation Disclaimer

This report interprets computational single-cell RNA-seq
analysis results. It does not establish causality, clinical
diagnosis, treatment response, or experimental validation.
